transplantologiyaТрансплантологияTransplantologiya. The Russian Journal of Transplantation2074-05062542-0909IPO Association of Transplantologists10.23873/2074-0506-2011-0-4-20-25transplantologiya-319Research ArticleПРОБЛЕМНЫЕ АСПЕКТЫPROBLEMATIC ASPECTSНизкомолекулярные пептидные препараты, полученные из культивированных стволовых клеток, при лечении острой почечной недостаточностиLow-molecular peptide preparations obtained from cultivated stem cells in the treatment of acute renal failureХубутияМ. Ш.KhubutiaM. Sh.ТемновА. А.TemnovA. A.ВагабовА. В.VagabovA. V.ЛебедевМ. П.LebedevM. P.СклифасА. Н.SklifasA. N.РоговК. А.RogovK. A.ФоминаО. П.FominaO. P.ВостриковаО. Ф.VostrikovaO. F.НИИ скорой помощи им. Н.В. СклифосовскогоРоссияSklifosovsky Research Institute for Emergency MedicineRussian FederationИнститут биофизики клеткиРоссияRestitute of cell biophysicsRussian FederationГКБ N° 4РоссияCity Clinical Hospital N° 4Russian Federation201121082018042025Copyright © Хубутия М.Ш., Темнов А.А., Вагабов А.В., Лебедев М.П., Склифас А.Н., Рогов К.А., Фомина О.П., Вострикова О.Ф., 20182018Хубутия М.Ш., Темнов А.А., Вагабов А.В., Лебедев М.П., Склифас А.Н., Рогов К.А., Фомина О.П., Вострикова О.Ф.Khubutia M.S., Temnov A.A., Vagabov A.V., Lebedev M.P., Sklifas A.N., Rogov K.A., Fomina O.P., Vostrikova O.F.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.jtransplantologiya.ru/jour/article/view/319

Приведены данные об эффективности использования низкомолекулярных пептидных препаратов, получаемых из культивированных клеток костного мозга, при лечении острой почечной недостаточности у экспериментальных животных.

Показано, что использование пептидных препаратов достоверно повышает выживаемость животных с острой почечной недостаточностью.

Data on the efficiency of low-molecular peptide preparations, selected from cultivated stem cells of marrow, in the treatment of acute kidney insufficiency in experimental animals are resulted. It is demonstrated that the use of peptide preparations reliably promotes survivability of experimental animals suffering from acute kidney insufficiency.

острая почечная недостаточностьстволовые клеткикостный мозгпептидыцисплатинacute kidney insufficiencystem cellsmarrowpeptidescisplatinReferencesAcute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury/R.L. Mehta //Crit. Care -2007. -N 11. -R 31.Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury/R.L. Mehta //Crit. Care -2007. -N 11. -R 31.Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy/R.W. Schrier //J. Clin. Invest. -2004. -Vol. 114.P. 5-14.Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy/R.W. Schrier //J. Clin. Invest. -2004. -Vol. 114.P. 5-14.Acute kidney injury, mortality, length of stay, and costs in hospitalized patients/G.M. Chertow //J. Am. Soc Nephrol. -2005. -Vol. 16. -P. 3365-3370.Acute kidney injury, mortality, length of stay, and costs in hospitalized patients/G.M. Chertow //J. Am. Soc Nephrol. -2005. -Vol. 16. -P. 3365-3370.An assessment of the RIFLE criteria for acute renal failure in hospitalized patients/S. Uchino //Crit. Care Med. -2006. -Vol. 34. -P. 1913-1917.An assessment of the RIFLE criteria for acute renal failure in hospitalized patients/S. Uchino //Crit. Care Med. -2006. -Vol. 34. -P. 1913-1917.RIFLE criteria for acute kidney injury is associated with hospital mortality in critically ill patient: A cohort analysis/E. Hoste //Crit. Care -2006. Vol.10. -R. 73-82,RIFLE criteria for acute kidney injury is associated with hospital mortality in critically ill patient: A cohort analysis/E. Hoste //Crit. Care -2006. Vol.10. -R. 73-82,Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure/Wang Wei //Am. J. Physiol. Renal. Physiol. -2003. -Mar., 284(3). -F. 532-537.Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure/Wang Wei //Am. J. Physiol. Renal. Physiol. -2003. -Mar., 284(3). -F. 532-537.Life-sparing effect of human cord blood-mesenchymal Stem Cells in experimental acute kidney injury/M. Morigi //Stem Cells. -2010. -Mar, 31, 28(3). -P. 513-522.Life-sparing effect of human cord blood-mesenchymal Stem Cells in experimental acute kidney injury/M. Morigi //Stem Cells. -2010. -Mar, 31, 28(3). -P. 513-522.Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice/M. Morigi //Stem. Cells. -2008. -Aug. 26(8). -P. 2075-2082.Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice/M. Morigi //Stem. Cells. -2008. -Aug. 26(8). -P. 2075-2082.Multilineage potential of adult human mesenchymal stem cells/M.F. Pittenger //Science. -1999. -Vol. 284. -P. 143-147.Multilineage potential of adult human mesenchymal stem cells/M.F. Pittenger //Science. -1999. -Vol. 284. -P. 143-147.Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates/S.M. Devine //Blood. -2003. -Vol. 101. -P. 2999 -3001.Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates/S.M. Devine //Blood. -2003. -Vol. 101. -P. 2999 -3001.Anjos-Afonso F, Siapati EK, Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions/F. Anjos-Afonso, E.K. Siapati, D. Bonnet//J. Cell. Sci. -2004. -Vol. 117. -P. 5655-5664.Anjos-Afonso F, Siapati EK, Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions/F. Anjos-Afonso, E.K. Siapati, D. Bonnet//J. Cell. Sci. -2004. -Vol. 117. -P. 5655-5664.Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis/S.C. Hung //Stem cells. -2007. -Vol. 25. -P. 2363-2370.Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis/S.C. Hung //Stem cells. -2007. -Vol. 25. -P. 2363-2370.Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms/F. Togel //Am. J. Physiol. Renal. Physiol. -2005. -Vol. 289. -F31-42.Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms/F. Togel //Am. J. Physiol. Renal. Physiol. -2005. -Vol. 289. -F31-42.Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages/M.K. Majumdar //J. Hematother. Stem. Cell. Res. -2000. -Vol. 9. -P. 841-848.Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages/M.K. Majumdar //J. Hematother. Stem. Cell. Res. -2000. -Vol. 9. -P. 841-848.Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure/M. Morigi //J. Am. Soc. Nephrol. -2004. -Vol. 15. -P. 1794 -1804.Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure/M. Morigi //J. Am. Soc. Nephrol. -2004. -Vol. 15. -P. 1794 -1804.ПРОБЛЕМНЫЕ АСПЕКТЫПРОБЛЕМНЫЕ АСПЕКТЫInsulin-like growth factor-1 sustains stem cell mediated renal repair/B. Imberti //J. Am. Soc. Nephrol. -2007. -18. -P. 2921-2928.Insulin-like growth factor-1 sustains stem cell mediated renal repair/B. Imberti //J. Am. Soc. Nephrol. -2007. -18. -P. 2921-2928.Stromal Cells Protect against Acute Tubular Injury via an Endocrine Effect/Bi. Baoyuan //J. Am. Soc. Nephrol. -2007. -Vol. 18. -P. 2486-2496.Stromal Cells Protect against Acute Tubular Injury via an Endocrine Effect/Bi. Baoyuan //J. Am. Soc. Nephrol. -2007. -Vol. 18. -P. 2486-2496.Переверзев, A.E. Кроветворные колониеобразующие клетки и физические стресс-факторы/А.Е. Переверзев//Л.: Наука, 1986. -С. 172.Переверзев, A.E. Кроветворные колониеобразующие клетки и физические стресс-факторы/А.Е. Переверзев//Л.: Наука, 1986. -С. 172.Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid/T. Martelius //BMC Infect. Dis. -2011. -Oct., 21, 11. -P. 281. - DOI: 10.1186/1471-2334-11-281Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid/T. Martelius //BMC Infect. Dis. -2011. -Oct., 21, 11. -P. 281. - DOI: 10.1186/1471-2334-11-281Зуев, B.A. Медленные вирусные инфекции человека и животных/В.А. Зуев. -М.: Медицина, 1988.Зуев, B.A. Медленные вирусные инфекции человека и животных/В.А. Зуев. -М.: Медицина, 1988.Зуев, В.А. Прионные болезни человека и животных: рук-во для врачей/В.А. Зуев, И.А. Завалишин, В.М. Ройхель. -М.: , 1999. -191 с.Зуев, В.А. Прионные болезни человека и животных: рук-во для врачей/В.А. Зуев, И.А. Завалишин, В.М. Ройхель. -М.: , 1999. -191 с.Denner, J. I nfectious risk in Xenotransplantation-what posttransplant screening for the human recipient?/J. Denner//Xenotransplantation. -2011. -May-Jun., Vol. 18(3). -P. 151-157. -doi: 10.111 l/j.1399-3089.2011.00636.x. Review.Denner, J. I nfectious risk in Xenotransplantation-what posttransplant screening for the human recipient?/J. Denner//Xenotransplantation. -2011. -May-Jun., Vol. 18(3). -P. 151-157. -doi: 10.111 l/j.1399-3089.2011.00636.x. Review.Композиция для стимулирования роста и регенерации клеток, а также способ ее получения: пат. № 2341270; опубл. 20.12.08, Бюл. № 35.Композиция для стимулирования роста и регенерации клеток, а также способ ее получения: пат. № 2341270; опубл. 20.12.08, Бюл. № 35.Композиция для стимулирования роста и регенерации клеток, (варианты), а также способ ее получения (варианты): пат. № 2391990; опубл.: 20.06.2010, Бюл. № 17.Композиция для стимулирования роста и регенерации клеток, (варианты), а также способ ее получения (варианты): пат. № 2391990; опубл.: 20.06.2010, Бюл. № 17.Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells/J.S. Duffield //J. Clin. Invest. -2005. -Vol. 115. -P. 1743-1755.Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells/J.S. Duffield //J. Clin. Invest. -2005. -Vol. 115. -P. 1743-1755.Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms/F. Togel //Am. J. Physiol. Renal. Physiol. -2005. -Vol. 289. -F31 -F42.Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms/F. Togel //Am. J. Physiol. Renal. Physiol. -2005. -Vol. 289. -F31 -F42.Caplan, A.I. Mesenchymal stem cells as trophic mediators/A.I, Caplan, J.E. Dennis//J. Cell. Biochem. -2006. -Vol. 98. -P. 1076 -1084.Caplan, A.I. Mesenchymal stem cells as trophic mediators/A.I, Caplan, J.E. Dennis//J. Cell. Biochem. -2006. -Vol. 98. -P. 1076 -1084.Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells/M.E. Groh //Exp. Hematol. -2005. -Vol. 33. -P. 928-934.Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells/M.E. Groh //Exp. Hematol. -2005. -Vol. 33. -P. 928-934.Aggarwal, S. Human mesenchymal stem cells modulate allogeneic immune cell responses/S. Aggarwal, M.F. Pittenger//Blood. -2005. -Feb. 15. -Vol. 105(4). -P. 1815-1822.Aggarwal, S. Human mesenchymal stem cells modulate allogeneic immune cell responses/S. Aggarwal, M.F. Pittenger//Blood. -2005. -Feb. 15. -Vol. 105(4). -P. 1815-1822.Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats/S.B. Miller //Am. J. Physiol. -1994. -Vol. 266. -F129 -F134.Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats/S.B. Miller //Am. J. Physiol. -1994. -Vol. 266. -F129 -F134.Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat/S.B. Miller //Proc. Natl. Acad. Sci. USA. -1992. -Vol. 89. -P. 11876 -11880.Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat/S.B. Miller //Proc. Natl. Acad. Sci. USA. -1992. -Vol. 89. -P. 11876 -11880.Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer/T. Asahara //Circulation. -1996. -Vol. 94. -P. 3291 -3302.Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer/T. Asahara //Circulation. -1996. -Vol. 94. -P. 3291 -3302.Vascular endothelial growth factor induces branching morphogenesis/ tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion / A. Karihaloo [et al.] // Mol. Cell. Biol. - 2005. - Vol. 25. - P. 7441-7448. 34.Interactions between human mesenchymal stem cells and natural killer cells / P.A. Sotiropoulou [et al.] // Stem. Cells. - 2006. - Vol. 24. - P. 74 -85.Vascular endothelial growth factor induces branching morphogenesis/ tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion / A. Karihaloo [et al.] // Mol. Cell. Biol. - 2005. - Vol. 25. - P. 7441-7448. 34.Interactions between human mesenchymal stem cells and natural killer cells / P.A. Sotiropoulou [et al.] // Stem. Cells. - 2006. - Vol. 24. - P. 74 -85.

The authors declare that there are no conflicts of interest present.